Fundamentals screen · refreshed after the Nov 10, 2026 close

Largest US companies: Healthcare

US-listed companies ranked by market capitalisation. Market capitalisation is shares outstanding multiplied by the latest close.

CriteriaCommon stockRanked by market cap847 stocks
#CompanyPriceTodayYTDP/EMkt cap
301ORICOric PharmaceuticalsHealthcare$8.91−3.47%+8.9%—$923.5M
302BBNXBeta BionicsHealthcare$16.52−2.54%−45.8%—$898.1M
303GLUEMonte Rosa TherapeuticsHealthcare$10.50−0.76%−33.0%—$897.2M
304LTGOLatigo BiotherapeuticsHealthcare$13.33−0.15%——$883.8M
305KIDSOrthoPediatricsHealthcare$33.48−1.50%+88.5%—$874.2M
306SNDXSyndax PharmaceuticalsHealthcare$9.49−0.63%−54.8%—$854.4M
307OBXObsidian TherapeuticsHealthcare$13.74+0.22%——$848.8M
308KODKEASTMAN KODAKHealthcare$8.47+2.17%+0.1%—$830.9M
309ALMSAlumisHealthcare$6.40−2.29%−34.4%—$828.4M
310LXRXLexicon PharmaceuticalsHealthcare$1.86+2.20%+61.7%—$828.1M
311RIGLRigel Pharmaceuticals Inc. (New)Healthcare$43.91+4.42%+2.5%2.7×$826.8M
312ANNXAnnexonHealthcare$4.21−0.47%−16.1%—$803.1M
313SLDBSolid BiosciencesHealthcare$7.17+2.14%+27.1%—$800.2M
314IRWDIronwood Pharmaceuticals, Inc. -Healthcare$4.81+2.78%+42.7%5.3×$796.3M
315AURAAura BiosciencesHealthcare$7.65−0.13%+40.4%—$796.2M
316QDELQuidelOrthoHealthcare$11.52−4.71%−59.7%—$790.4M
317DNAGinkgo Bioworks HoldingsHealthcare$12.01−2.91%+44.5%—$778.5M
318SGMTSagimet Biosciences Inc. Series AHealthcare$10.89+0.55%+84.0%—$772.2M
319BVSBioventusHealthcare$11.18+1.50%+50.3%12.7×$765.5M
320ATTOAttovia TherapeuticsHealthcare$16.64+4.26%——$760.7M
321COLLCollegium PharmaceuticalHealthcare$24.47−0.97%−47.1%19.9×$760.4M
322CTKBCytek BiosciencesHealthcare$5.79−1.70%+14.7%—$757.2M
323ARDXArdelyxHealthcare$3.01+2.73%−48.4%—$756.6M
324JANXJanux TherapeuticsHealthcare$12.04−5.64%−12.8%—$736.6M
325CGEMCullinan TherapeuticsHealthcare$11.23−4.26%+8.5%—$729.1M
326SANASana BiotechnologyHealthcare$2.43−1.42%−40.3%—$728.1M
327NVCTNuvectis PharmaHealthcare$21.08+0.29%+179.2%—$724.9M
328FLGTFulgent GeneticsHealthcare$25.78−1.41%−1.9%—$720.3M
329MOVMovado GroupHealthcare$32.11+0.25%+55.7%17.3×$716.4M
330CADLCandel TherapeuticsHealthcare$9.35−1.48%+65.5%—$715.4M
331MTRIMentari TherapeuticsHealthcare$12.20−23.75%——$711.3M
332ZVRAZevra TherapeuticsHealthcare$11.92−1.81%+33.0%9.2×$709.3M
333PRMEPrime MedicineHealthcare$3.90−9.30%+12.4%—$707.4M
334DCTHDelcath SystemsHealthcare$20.10−0.84%+99.0%1,314.4×$699.2M
335ACHVAchieve Life SciencesHealthcare$6.78+0.89%+36.4%—$699.0M
336AVBPArriVent BioPharmaHealthcare$13.49−4.73%−33.0%—$697.7M
337PACBPacific Biosciences of CaliforniaHealthcare$2.24−5.08%+19.8%—$696.3M
338IMMXImmix BiopharmaHealthcare$8.35−2.57%+59.7%—$692.2M
339CLYMClimb BioHealthcare$11.74+6.63%+193.5%—$689.6M
340FDMT4D Molecular TherapeuticsHealthcare$12.46−0.16%+66.1%—$688.3M
341DSGNDesign TherapeuticsHealthcare$10.65−1.39%+13.5%—$682.0M
342BCAXBicara TherapeuticsHealthcare$10.18+2.00%−39.5%—$675.8M
343KURAKura OncologyHealthcare$7.570.00%−27.1%—$673.4M
344WVEWave Life SciencesHealthcare$3.41−2.01%−79.9%—$672.6M
345APMDApnimedHealthcare$15.86+0.32%——$660.3M
346ACRSAclaris TherapeuticsHealthcare$4.15−2.12%+37.9%—$658.2M
347OLMAOlema PharmaceuticalsHealthcare$7.27−1.22%−70.9%—$636.9M
348GERNGeronHealthcare$0.9742−2.24%−26.2%—$627.6M
349SGHTSight SciencesHealthcare$10.75−2.36%+35.6%—$597.5M
350TCMDTactile Systems TechnologyHealthcare$26.62+0.11%−8.2%25.0×$596.3M

Method & sources

Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology

Informational screen, not a recommendation.